Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Cash Flow PerformanceFair Value
Percentile Rank71
Studio
Year-over-Year Change

Free cash flow yield

Latest
-5.14%
↑ 22% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive growthFair Value
Average
-6.60%
Historical baseline
PeriodValueYoY Change
2025-5.14%+20.9%
2024-6.50%-22.2%
2023-5.32%-74.1%
2022-3.05%-25.9%
2021-2.42%+69.8%
2020-8.04%+32.9%
2019-11.99%-9.8%
2018-10.92%-104.8%
2017-5.33%+26.3%
2016-7.24%-